Hiv Clinical Trial
Official title:
Efficacy Trial of Life Simulation Game to Routinize Adolescent HIV Testing
| NCT number | NCT04917575 |
| Other study ID # | NCR191708 |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | June 24, 2021 |
| Est. completion date | September 2024 |
This study will aim to assess the acceptability, usability and efficacy of using state-of-the-art video game technology to increase HIV testing among adolescents and young adults (AYA) ages 13-24. AYA often lack awareness of their personal risk of contracting HIV and where to go for testing and care. This lack of awareness has contributed to poor uptake of HIV testing among AYA despite engagement in high risk behaviors. The goal of this project is to harness this strong motivation to play games to increase HIV testing. Previous games for behavior change have yielded early success for increasing target behaviors among their sample populations, yet research on increasing HIV testing among AYA through gaming has been limited. This intervention builds on prior formative work and is designed to offer AYA personally-tailored risk messages and supports their accessibility to HIV testing and prevention services through an innovative gaming approach that is sharable over social media with in-game rewards for sharing the game with peers. The specific aim of this study is to determine the efficacy of a life-simulation game in changing HIV testing, knowledge, and risk behaviors among AYA at risk for HIV.
| Status | Recruiting |
| Enrollment | 300 |
| Est. completion date | September 2024 |
| Est. primary completion date | September 2024 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 13 Years to 24 Years |
| Eligibility | Inclusion Criteria: - age 13-24 - self-reported HIV negative or unknown status - self-reported ever sexually active - resident of the DC metropolitan region which includes the District of Columbia, Maryland and Virginia for at least the next 6 months - Is able to provide informed consent or assent - able to complete all study procedures in English - has own mobile phones and be willing to use them for the study. |
| Country | Name | City | State |
|---|---|---|---|
| United States | George Washington University Milken School of Public Health | Washington | District of Columbia |
| Lead Sponsor | Collaborator |
|---|---|
| George Washington University | Media Rez |
United States,
Castel AD, Wilbourn B, Trexler C, D'Angelo LD, Greenberg D. A Digital Gaming Intervention to Improve HIV Testing for Adolescents and Young Adults: Protocol for Development and a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2021 Jun 24;10(6):e29792. doi: 10.2196/29792. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | HIV testing | Self-reported HIV testing in the past 6 months | prior 6 months | |
| Secondary | Intent to test for HIV | Intent to test will be assessed using a validated 6-point Likert scale | baseline, 1, 3, 6 months | |
| Secondary | HIV knowledge | 18-item scale | baseline, 1, 3, 6 months | |
| Secondary | HIV risk perception and behaviors | 8-item scale and perceived likelihood of getting infected (0-100%) | baseline, 1, 3, 6 months | |
| Secondary | Knowledge of PrEP | Has participant heard of PrEP at specified time period | baseline, 1, 3, 6 months | |
| Secondary | CDC risk estimator scores | baseline, 1, 3, 6 months | ||
| Secondary | Frequency of game use | 1, 3, 6 months | ||
| Secondary | PrEP screening | ever been screened for PrEP eligibility | baseline, 1, 3, 6 months | |
| Secondary | PrEP use/uptake | been prescribed/taken PrEP | baseline, 1, 3, 6 months | |
| Secondary | PrEP locator use | Number of linkages to PrEP locator | baseline, 1, 3, 6 months | |
| Secondary | Duration of game use | 1, 3, 6 months | ||
| Secondary | Reasons for continued or discontinued use of game | 1, 3, 6 months | ||
| Secondary | HIV locator use | Number of linkage to HIV testing locator | baseline, 1, 3, 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |